Archives: Agenda

• Understanding how political priorities and leadership changes shape FDA expectations
• Balancing accelerated approvals and innovation with growing demands for robust evidence
• Navigating uncertainty around incentives, vouchers, and evolving policy frameworks
• Building flexible development strategies that can adapt to regulatory and political shifts

Moderator: Tia Williamson, Associate Director Development Operations Global Monitoring, Incyte

• Regulatory strategy development and AI
• Development of the AI FDA Roadmapper^tm.
• Applying the roadmap in practice within clinical development settings
• Navigating regulatory uncertainty when implementing AI across clinical functions
• Outcomes, learnings and key challenges from real-world application

Visit our exhibitors’ booths throughout the day and collect stamps in order to enter our Prize Draw and be in for a chance of winning Apple devices or Amazon gift cards. The Prize Draw will take place in the Exhibition Hall, make sure you don’t miss out!

Turning large-scale perception data into smarter engagement strategies

• Sharing insights from CISCRP’s 2025 survey of 12,000+ individuals, including 4,000+ past trial participants, to unpack patient and public perceptions of AI in clinical research
• Exploring what the data means in practice, highlighting concrete actions researchers, sponsors, and sites should take to build trust, improve communication, and use AI responsibly
• Applying engagement and communication findings to recruitment and retention, including trial information-seeking behaviors, DCT preferences, results sharing expectations, and demographic-specific insights